Discover a study that has revealed a new potential mechanism of understanding inflammation in ulcerative colitis.

Johnson & Johnson (J&J) has shared positive long-term results from a phase 3 trial of its dual-acting IL-23 inhibitor Tremfya ...

Johnson & Johnson (NYSE:JNJ) recently presented promising data on TREMFYA® for ulcerative colitis and Crohn's disease, ...

Positive top line results from rusfertide Phase 3 VERIFY trial in polycythemia vera (PV) announced; full data selected for oral presentation during plenary session at ASCO on June 1st Conference call ...

To evaluate the therapeutic value of mirikizumab in IBD, researchers conducted a systematic review and meta-analysis of ...

NET LOSS FORECAST: Takeda is expected to post a net loss of 81.7 billion yen, equivalent to $573.7 million, for the three months ended March, according to a Visible Alpha poll of analysts. That ...

Stroke and coronary artery disease were the primary causes linked to the deaths of all participants with autoimmune disease, ...

For an accessible version of this Press Release, please visit On track for 30% operating profit margin by 2027 in line with ...

Finding a cure for inflammatory bowel disease (IBD) would mean reducing treatment waste, according to Ashwin N.

Women with the autoimmune diseases rheumatoid arthritis, lupus or systemic sclerosis may have a higher rate of death related to cardiovascular disease than men with the autoimmune diseases, according ...

Beans, legumes and lentils are another great family of foods to look at for zinc. Lentils are packed with fiber, which ...

The possibility that it was shingles never crossed her mind. After all, she’d always heard it was an illness that mainly ...